An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy

An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy

The study was to compare treatment preference, efficacy, and tolerability of sildenafil citrate (sildenafil) and tadalafil for treating erectile dysfunction (ED) in Chinese men naοve to phosphodiesterase 5 (PDE5) inhibitor therapies. This multicenter, randomized, open-label, crossover study evaluate...

Full description

Bibliographic Details
Main Authors: Wen-Jun Bai, Hong-Jun Li, Yu-Tian Dai, Xue-You He, Yi-Ran Huang, Ji-Hong Liu, Sebastian Sorsaburu, Chen Ji, Jian-Jun Jin, Xiao-Feng Wang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-02-01
Series:Asian Journal of Andrology
Subjects:
erectile dysfunction; patient preference; phosphodiesterase 5 inhibitors
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=1;spage=61;epage=67;aulast=Bai

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=1;spage=61;epage=67;aulast=Bai

Similar Items